Interleukin-16

Journal of Leukocyte Biology

Volumn 67, Issue 6, 2000, Pages 757-766

  Cruikshank, W W ^a   Kornfeld, H ^a   Center, D M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD4; HIV 1; Inflammation

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 16; MESSENGER RNA;

ANIMAL CELL; GENE STRUCTURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS; T LYMPHOCYTE;

EID: 0033840197     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.67.6.757     Document Type: Review

References (82)

1. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated monuclear cells
2. Modulation of lymphocyte migration by human lymphokines. II. Purification of lymphotactic factor (LCF)
3. Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor
4. Processing and activation of interleukin 16 by caspase 3
5. + T cells is activation dependent
6. Interleukin-1 is processed and released during apoptosis
7. + T cells
8. Interleukin-16 or not?
9. + T cells in vitro
10. + T cells is independent of transcription and translation: Evidence for constitutive protein synthesis and storage
11. + T lymphocyte chemoattractant factor, Interleukin 16
12. Human eosinophils elaborate the lymphocyte chemoattractants: IL-16 (lymphocyte chemoattractant factor) and RANTES
13. Bronchial epithelial cells of patients with asthma release chemoattractant factors for T lymphocytes
14. Increased expression of IL-16 in bronchial mucosa of subjects with atopic asthma
15. Molecular and functional analysis of a lymphocyte chemoattractant factor: Association of biologic function with CD4 expression
16. Early identification of IL-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1α (MIP1α) in bronchoalveolar lavage fluid of antigen challenged asthmatics
17. Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site
18. ZO-1, DIgA and PSD-95/SAP90: Homologous proteins in tight, septate and synaptic cell junctions
19. Identification of domains in IL-16 critical for biologic activity
20. Neuronal interleukin-16 (NIL-16): A dual function PDZ domain protein
21. Molecular cloning and expression of Rhesus Macaque and Sooty Mangabey interleukin 16: Biologic activity and effect on simian immunodeficiency virus infection and/or replication
22. HIV suppression by interleukin-16
23. Conservation of structure and function between murine and human interleukin 16
24. Involvement of IL-16 in the induction of airway hyperresponsiveness and upregulation of IgE in a murine model of allergic asthma
25. Assignment of human interleukin 16 (IL16) to chromosome 15q26.3 by radiation hybrid mapping
26. The gene encoding mouse interleukin-16 consists of seven exons and maps to chromosome 7 D2-D3
27. Molecular cloning and expression of feline interleukin-16
28. GA-binding protein factors, in concert with the coactivator CREB binding protein/p300, control the induction of the interleukin 16 promoter in T lymphocytes
29. Tissue and T cell distribution of precursor and mature IL-16
30. Functional characteristics of histamine receptor-bearing mononuclear cells. II. Identification and characterization of two histamine-induced human lymphokines that inhibit lymphocyte migration
31. A role for IL-16 in the cross-talk between dendritic cells and T cells
32. Interleukin 16 and its functions as a CD4 ligand
33. Selective secretion of IL-16 into the airways of asthmatics following subsegmental challenge with histamine: Phenotypic differences between asthmatics, atopics and normals
34. The expression of lymphocyte chemoattractant factor (LCF) in human bronchial epithelial cells
35. + T-cell infiltration with increased IL-16 gene expression in atopic dermatitis
36. + T lymphocytes in rheumatoid arthritis
37. Activation of CD4 associated p56 lck by the lymphocyte chemoattractant factor. Dissociation of kinase enzymatic activity with chemotactic response
38. Lymphocyte chemoattractant factor (LCF) induces CD4-dependent intracytoplasmic signalling in lymphocytes
39. Identification of a CD4 domain required for IL-16 binding and lymphocyte activation
40. Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset
41. + lymphocytes and monocytes
42. CD4-mediated stimulation of human eosinophils: Lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration
43. Reciprocal desensitization of CCR5 and CD4 is mediated by IL-16 and MIP-1 respectively
44. Constitutive cell surface association between CD4 and CCR5
45. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
46. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
47. Expression of α4β7 integrin on eosinophils and modulation of α4-integrin-mediated eosinophil adhesion via CD4
48. Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD)
49. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120
50. Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation
51. Dimeric association and segmental variability in the structure of human CD4
52. IL-16 and other CD4 ligand-induced migration is dependent upon protein kinase C
53. + T cells by interleukin 16 and interleukin 2
54. + macrophages
55. Biologic activities of interleukin 16
56. + cell lines by IL-16
57. + cell-specific chemoattractant interleukin-16 in mycosis fungoides
58. Maturation of B cell precursors is impaired in thymic-deprived nude and old mice
59. Signals transduced through the CD4 molecule on T lymphocytes activate NF-kappa B
60. + T cells
61. Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine kinase p56(Ick) with CD4 in human T lymphocytes
62. Biologic activities of HIV-1 envelope glycoprotein: The effects of crosslinking
63. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor
64. HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes
65. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion
66. Lymphocyte activation by HIV-1 envelope glycoprotein
67. Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein gp120 of human immunodeficiency virus
68. Internalization of HIV glycoprotein gp120 is associated with down-modulation and membrane CD4 and p56(Ick) together with impairment of T cell activation
69. Perturbation of the T4 molecule transmits a negative signal to T cells
70. The CD4 ligand interleukin 16 inhibits the mixed lymphocyte reaction
71. Suppression of anti-CD3 stimulated T cell proliferation by IL-16
72. + T cells
73. Analysis of the CD4 coreceptor and activation-induced costimulatory molecules in antigen-mediated T lymphocyte death
74. Role of IL-16 in HIV replication
75. Interleukin-16 represses HIV-1 promoter activity
76. + cells transfected with IL-16 cDNA are resistant to HIV-1 infection: Inhibition of mRNA expression
77. Interleukin-16 inhibits human immunodefficiency virus type 1 entry and replication in macrophages and in dendritic cells
78. RIL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: Correlation with its ability to block culture-induced down-modulation of Bcl-2
79. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection
80. Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir
81. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis
82. Histamine: An early messenger in inflammatory and immune reactions